Biopsychosocial analysis of antibiotic use for the prevention or management of COVID-19 infections: A scoping review

[1]  Narelle Warren,et al.  Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance , 2021, PloS one.

[2]  J. Begovac,et al.  Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020 , 2021, medRxiv.

[3]  Nisrine Haddad,et al.  Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions , 2021, Antibiotics.

[4]  Fentaw Tadese,et al.  Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury? , 2021, The American journal of tropical medicine and hygiene.

[5]  P. Meybohm,et al.  Antibiotics for the treatment of COVID-19. , 2021, The Cochrane database of systematic reviews.

[6]  Mohammad-Salar Hosseini,et al.  Antibiotic resistance: A disregarded concern for misuse of azithromycin in COVID-19 treatment , 2021, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[7]  D. Morgan,et al.  Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients , 2021, Antimicrobial agents and chemotherapy.

[8]  D. D. de Vries,et al.  The Pandemic beyond the Pandemic: A Scoping Review on the Social Relationships between COVID-19 and Antimicrobial Resistance , 2021, International journal of environmental research and public health.

[9]  G. Dimitriou,et al.  Parental Knowledge, Attitude, and Practices on Antibiotic Use for Childhood Upper Respiratory Tract Infections during COVID-19 Pandemic in Greece , 2021, Antibiotics.

[10]  P. Lacor,et al.  Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers , 2021, Internal and Emergency Medicine.

[11]  Y. Adebisi,et al.  The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries , 2021, Tropical Medicine and Health.

[12]  S. Garg.  Antibiotic misuse during COVID-19 Pandemic: A Recipe for Disaster , 2021, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[13]  I. Yunusa,et al.  Repurposing of antibiotics for clinical management of COVID-19: a narrative review , 2021, Annals of clinical microbiology and antimicrobials.

[14]  R. Gómez Huelgas,et al.  Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID , 2021, PloS one.

[15]  Y. Khader,et al.  An Overview of the Treatment Options Used for the Management of COVID-19 in Pakistan: Retrospective Observational Study , 2021, JMIR Public Health and Surveillance.

[16]  C. Feldman,et al.  The role of co-infections and secondary infections in patients with COVID-19 , 2021, Pneumonia.

[17]  L. Westblade,et al.  Bacterial Coinfections in Coronavirus Disease 2019 , 2021, Trends in Microbiology.

[18]  S. de Lusignan,et al.  Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial , 2021, The Lancet.

[19]  M. Rubio-Rivas,et al.  Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy , 2021, BMC Infectious Diseases.

[20]  Mitchell K. Byrne,et al.  Self-Medication with Antibiotics for Protection against COVID-19: The Role of Psychological Distress, Knowledge of, and Experiences with Antibiotics , 2021, Antibiotics.

[21]  Pierre Smith,et al.  Psychological distress associated with the COVID-19 pandemic and suppression measures during the first wave in Belgium , 2021, BMC Psychiatry.

[22]  E. Haddad,et al.  Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy , 2021, Journal of infection and public health.

[23]  Haitham Saeed,et al.  Antibiotic misuse and compliance with infection control measures during COVID‐19 pandemic in community pharmacies in Egypt , 2021, International journal of clinical practice.

[24]  D. MacFadden,et al.  Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis , 2021, Clinical Microbiology and Infection.

[25]  H. Ukuhor.  The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics , 2020, Journal of Infection and Public Health.

[26]  V. Kiri,et al.  Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria , 2020, Frontiers in Public Health.

[27]  D. Ekouevi,et al.  Assessment of self-medication practices in the context of COVID-19 outbreak in Togo , 2020 .

[28]  C. M. Saad-Roy,et al.  Economic and Behavioral Influencers of Vaccination and Antimicrobial Use , 2020, Frontiers in Public Health.

[29]  W. Wan,et al.  Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19 , 2020, International Immunopharmacology.

[30]  D. Shin,et al.  A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea , 2020, Clinical Microbiology and Infection.

[31]  A. Kerckhoffs,et al.  Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands , 2020, Infectious diseases.

[32]  M. Aljofan,et al.  Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond , 2020, Antiviral chemistry & chemotherapy.

[33]  N. Volkow,et al.  Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19. , 2020, JAMA psychiatry.

[34]  A. Ströhle,et al.  Associations between COVID-19 related media consumption and symptoms of anxiety, depression and COVID-19 related fear in the general population in Germany , 2020, European Archives of Psychiatry and Clinical Neuroscience.

[35]  محمد حسین حیدرگوی.  بررسی تأثیر شیوع بیماری کرونا بر مصرف بیرویه آنتیبیوتیک , 2020 .

[36]  M. Casagrande,et al.  The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population , 2020, Sleep Medicine.

[37]  Wenhong Zhang,et al.  COVID-19: treating and managing severe cases , 2020, Cell Research.

[38]  Amir Moghanibashi-Mansourieh.  Assessing the anxiety level of Iranian general population during COVID-19 outbreak , 2020, Asian Journal of Psychiatry.

[39]  H. Goudarzi,et al.  Macrolide treatment for COVID-19: Will this be the way forward? , 2020, Bioscience trends.

[40]  Min Zhao,et al.  A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations , 2020, General Psychiatry.

[41]  R. Parker.  Novel coronavirus (2019-nCoV) , 2020 .

[42]  V. Solomon,et al.  Evidence of factors influencing self-medication with antibiotics in low and middle-income countries: a systematic scoping review. , 2019, Public health.

[43]  A. Kantele,et al.  Stand-by antibiotics encourage unwarranted use of antibiotics for travelers' diarrhea: A prospective study. , 2019, Travel medicine and infectious disease.

[44]  Kwaku Poku Asante,et al.  To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana , 2018, Journal of Pharmaceutical Policy and Practice.

[45]  A. McLachlan,et al.  Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review. , 2018, International journal of antimicrobial agents.

[46]  J. Chilongola,et al.  Prevalence, determinants and knowledge of antibacterial self-medication: A cross sectional study in North-eastern Tanzania , 2018, PloS one.

[47]  J. Sareen,et al.  Self‐medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature , 2018, Depression and anxiety.

[48]  H. Kusnanto,et al.  Biopsychosocial model of illnesses in primary care: A hermeneutic literature review , 2018, Journal of family medicine and primary care.

[49]  K. Ward,et al.  Understanding Postdisaster Substance Use and Psychological Distress Using Concepts from the Self-Medication Hypothesis and Social Cognitive Theory , 2018, Journal of psychoactive drugs.

[50]  D. Raoult,et al.  Azithromycin Inhibits the Replication of Zika Virus , 2018 .

[51]  A. Sheikh,et al.  Community pharmacists perspectives about reasons behind antibiotics dispensing without prescription: a qualitative study , 2018 .

[52]  Pierre Pluye,et al.  The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers , 2018, Educ. Inf..

[53]  Rachel A. Smith,et al.  Reducing unwarranted antibiotic use for pediatric acute otitis media: the influence of physicians' explanation and instruction on parent compliance with ‘watchful waiting’ , 2017 .

[54]  N. Safdar,et al.  Social determinants of antibiotic misuse: a qualitative study of community members in Haryana, India , 2017, BMC Public Health.

[55]  N. Karami,et al.  Community pharmacists' knowledge, attitude, and practices towards dispensing antibiotics without prescription (DAwP): a cross-sectional survey in Makkah Province, Saudi Arabia. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[56]  D. Akena,et al.  Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries , 2015, BMC Public Health.

[57]  M. Kadir,et al.  Self-medication with antibiotics among non-medical university students of Karachi: a cross-sectional study , 2014, BMC Pharmacology and Toxicology.

[58]  H. Khan,et al.  Determinants of Increasing Trend of Self-Medication in a Pakistani Community , 2014 .

[59]  J. Buckner,et al.  A BIOPSYCHOSOCIAL MODEL OF SOCIAL ANXIETY AND SUBSTANCE USE , 2013, Depression and anxiety.

[60]  Y. Jang,et al.  Macrolide Therapy in Respiratory Viral Infections , 2012, Mediators of inflammation.

[61]  R. Jiménez-García,et al.  Sex—Differences on self‐medication in Spain , 2010, Pharmacoepidemiology and drug safety.

[62]  D. Levac,et al.  Scoping studies: advancing the methodology , 2010, Implementation science : IS.

[63]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[64]  C. McLean,et al.  Brave men and timid women? A review of the gender differences in fear and anxiety. , 2009, Clinical psychology review.

[65]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[66]  Jonathan A. Smith.  Qualitative Psychology: A Practical Guide to Research Methods , 2006, QMiP Bulletin.

[67]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[68]  R. Epstein,et al.  The Biopsychosocial Model 25 Years Later: Principles, Practice, and Scientific Inquiry , 2004, The Annals of Family Medicine.

[69]  Robert Sitton.  On Europe , 1992, Current History.

[70]  C. Dolea,et al.  World Health Organization , 1949, International Organization.